Brief: Iconovo Updates Its Long-Term Financial Targets

Iconovo AB

01/06/2022 07:20

June 1 (Reuters) - Iconovo AB  ICO.ST :
    * ICONOVO UPDATES ITS LONG-TERM FINANCIAL TARGETS - SEES
STRONG
REVENUE GROWTH WITH A HIGH MARGIN
    * IN 2027, THE COMPANY EXPECTS TO ACHIEVE SALES OF SEK 250
MILLION
    * TARGET FOR OPERATING PROFIT IN THE SAME YEAR IS SEK 125
MILLION,
CORRESPONDING TO A OPERATING MARGIN OF 50 PERCENT
    * ONE THIRD OF SALES IS EXPECTED TO FROM ICONOVO'S OWN
PHARMACEUTICAL SALES IN THE NORDIC REGION THROUGH ITS SUBSIDIARY
ICONOVO PHARMA
    * FINANCIAL TARGETS DO NOT INCLUDE POTENTIAL ROYALTY INCOME
FROM
CO'S PARTNER ISR LINKED TO NASAL COVID-19 VACCINE

Source text for Eikon:  ID:nMFN7nKhT0 
Further company coverage:  ICO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))